Advertisement

The Participation of Mesenchymal Stem Cells in Tumor Stroma Formation and Their Application as Targeted-Gene Delivery Vehicles

  • B. Hall
  • M. Andreeff
  • F. MariniEmail author
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 180)

Abstract

Recent evidence suggests that mesenchymal stem cells (MSC) selectively proliferate to tumors and contribute to the formation of tumor-associated stroma. The biological rationale for tumor recruitment of MSC remains unclear but may represent an effort of the host to blunt tumor cell growth and improve survival. There is mounting experimental evidence that normal stromal cells can revert malignant cell behavior, and separate studies have demonstrated that stromal cells can enhance tumor progression after acquisition of tumor-like genetic lesions. Together, these observations support the rationale for modifying normal MSC to deliver therapeutic proteins directly into the tumor microenvironment. Modified MSC can produce high concentrations of antitumor proteins directly within the Tumor mass, which have been shown to blunt tumor growth kinetics in experimental animal model systems. In this chapter we will address the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.

Keywords

Mesenchymal Stem Cell (MSC) Tumor Microenvironment Tumor-associated Fibroblast (TAF) Stromagenesis Myofibroblast Desmoplasia Tumor Stroma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA (2004) Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78:503–508PubMedGoogle Scholar
  2. Almeida-Porada G, Porada C, Zanjani ED (2004) Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation. Int J Hematol 79:1–6PubMedGoogle Scholar
  3. Baksh D, Song L, Tuan RS (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301–316PubMedGoogle Scholar
  4. Ballas CB, Zielske SP, Gerson SL (2002) Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38:20–28PubMedGoogle Scholar
  5. Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874–882PubMedGoogle Scholar
  6. Barcellos-Hoff MH, Ravani SA (2000) Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60:1254–1260PubMedGoogle Scholar
  7. Bianchi G, Muraglia A, Daga A, Corte G, Cancedda R, Quarto R (2001) Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Regen 9:460–466PubMedGoogle Scholar
  8. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17–23PubMedGoogle Scholar
  9. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46–54PubMedGoogle Scholar
  10. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65:3126–3135PubMedGoogle Scholar
  11. Burns MJ, Weiss W (2003) Targeted therapy of brain tumors utilizing neural stem and progenitor cells. Front Biosci 8:e228–234PubMedGoogle Scholar
  12. Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259–264PubMedGoogle Scholar
  13. Chan J, O’Donoghue K, de la Fuente J, et al (2005) Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93–102PubMedGoogle Scholar
  14. Chen J, Wang C, Lu S, et al (2005) In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res 319:429–438PubMedGoogle Scholar
  15. Chen SL, Fang WW, Ye F, et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92–95PubMedGoogle Scholar
  16. Chung LW, Baseman A, Assikis V, Zhau HE (2005) Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 173:10–20PubMedGoogle Scholar
  17. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867PubMedGoogle Scholar
  18. Cunha GR, Hom YK (1996) Role of mesenchymal-epithelial interactions in mammary gland development. J Mammary Gland Biol Neoplasia 1:21–35PubMedGoogle Scholar
  19. Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107:1–10PubMedGoogle Scholar
  20. Dai W, Hale SL, Martin BJ, et al (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112:214–223PubMedGoogle Scholar
  21. De Kok IJ, Drapeau SJ, Young R, Cooper LF (2005) Evaluation of mesenchymal stem cells following implantation in alveolar sockets: a canine safety study. Int J Oral Maxillofac Implants 20:511–518PubMedGoogle Scholar
  22. De Palma M, Venneri MA, Roca C, Naldini L (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9:789–795PubMedGoogle Scholar
  23. De Palma M, Venneri MA, Galli R, et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211–226PubMedGoogle Scholar
  24. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429–447PubMedGoogle Scholar
  25. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875–884PubMedGoogle Scholar
  26. Dennis JE, Cohen N, Goldberg VM, Caplan AI (2004) Targeted delivery of progenitor cells for cartilage repair. J Orthop Res 22:735–741PubMedGoogle Scholar
  27. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999–3001PubMedGoogle Scholar
  28. Direkze NC, Forbes SJ, Brittan M, et al (2003) Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21:514–520PubMedGoogle Scholar
  29. Direkze NC, Hodivala-Dilke K, Jeffery R, et al (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64:8492–8495PubMedGoogle Scholar
  30. Djouad F, Plence P, Bony C, et al (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837–3844PubMedGoogle Scholar
  31. Dong J, Grunstein J, Tejada M, et al (2004) VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800–2810PubMedGoogle Scholar
  32. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659PubMedGoogle Scholar
  33. Emura M, Ochiai A, Horino M, Arndt W, Kamino K, Hirohashi S (2000) Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1. In Vitro Cell Dev Biol Anim 36:77–80PubMedGoogle Scholar
  34. Erices AA, Allers CI, Conget PA, Rojas CV, Minguell JJ (2003) Human cord blood-derived mesenchymal stem cells home and survive in them arrow of immunodeficient mice after systemic infusion. Cell Transplant 12:555–561PubMedGoogle Scholar
  35. Evans CH, Robbins PD, Ghivizzani SC, et al (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A 102:8698–8703PubMedGoogle Scholar
  36. Feldmann RE Jr, Bieback K, Maurer MH, et al (2005) Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 26:2749–2758PubMedGoogle Scholar
  37. Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990–998PubMedGoogle Scholar
  38. Fierro FA, Sierralta WD, Epunan MJ, Minguell JJ (2004)Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 21:313–319PubMedGoogle Scholar
  39. Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3:643–651PubMedGoogle Scholar
  40. Folkman J (2004) Endogenous angiogenesis inhibitors. Apmis 112:496–507PubMedGoogle Scholar
  41. Forbes SJ, Russo FP, Rey V, et al (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126:955–963PubMedGoogle Scholar
  42. Forte G, Minieri M, Cossa P, et al (2006) Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24:23–33PubMedGoogle Scholar
  43. Fukuda K (2003) Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant 32[Suppl 1]:S25–27PubMedGoogle Scholar
  44. Gallego MI, Binart N, Robinson GW, et al (2001) Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229:163–175PubMedGoogle Scholar
  45. Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416–1423PubMedGoogle Scholar
  46. Gojo S, Umezawa A (2003) Plasticity of mesenchymal stem cells-regenerative medicine for diseased hearts. Hum Cell 16:23–30PubMedGoogle Scholar
  47. Gronthos S, Zannettino AC, Hay SJ, et al (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827–1835PubMedGoogle Scholar
  48. Haffen K, Kedinger M, Simon-Assmann P (1987) Mesenchyme-dependent differentiation of epithelial progenitor cells in the gut. J Pediatr Gastroenterol Nutr 6:14–23PubMedGoogle Scholar
  49. Hamada H, Kobune M, Nakamura K, et al (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149–156PubMedGoogle Scholar
  50. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMedGoogle Scholar
  51. Harrington K, Alvarez-Vallina L, Crittenden M, et al (2002) Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther 13:1263–1280PubMedGoogle Scholar
  52. Hasebe T, Mukai K, Tsuda H, Ochiai A (2000) New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int 50:263–272PubMedGoogle Scholar
  53. Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123:1001–1011PubMedGoogle Scholar
  54. Hombauer H, Minguell JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 82:1290–1296PubMedGoogle Scholar
  55. Honma T, Honmou O, Iihoshi S, et al (2006) Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199:56–66PubMedGoogle Scholar
  56. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313PubMedGoogle Scholar
  57. Houghton J, Stoicov C, Nomura S, et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571PubMedGoogle Scholar
  58. Hurwitz DR, Kirchgesser M, Merrill W, et al (1997) Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 8:137–156PubMedGoogle Scholar
  59. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE (2002) The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62:5351–5357PubMedGoogle Scholar
  60. In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338–1345Google Scholar
  61. Ishii G, Sangai T, Oda T, et al (2003) Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309:232–240PubMedGoogle Scholar
  62. Ishii G, Sangai T, Ito T, et al (2005) In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117:212–220PubMedGoogle Scholar
  63. Jankowski K, Kucia M, Wysoczynski M, et al (2003) Both hepatocyte growth factor(HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 63:7926–7935PubMedGoogle Scholar
  64. Jiang H, Conrad C, Fueyo J, Gomez-Manzano C, Liu TJ (2003) Oncolytic adenoviruses for malignant glioma therapy. Front Biosci 8:d577–588PubMedGoogle Scholar
  65. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J (2006) Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 66:2146–2152PubMedGoogle Scholar
  66. Kammertoens T, Schuler T, Blankenstein T (2005) Immunotherapy: target the stroma to hit the tumor. Trends Mol Med 11:225–231PubMedGoogle Scholar
  67. Kan I, Melamed E, Offen D (2005) Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets 6:31–41PubMedGoogle Scholar
  68. Kaplan RN, Riba RD, Zacharoulis S, et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827PubMedGoogle Scholar
  69. Kassem M (2004) Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 6:369–374PubMedGoogle Scholar
  70. Kenny PA, Bissell MJ (2003) Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 107:688–695PubMedGoogle Scholar
  71. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A (2005) Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res 65:1627–1630PubMedGoogle Scholar
  72. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W (2002) Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215–222PubMedGoogle Scholar
  73. Kraitchman DL, Tatsumi M, Gilson WD, et al (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451–1461PubMedGoogle Scholar
  74. Kunz-Schughart LA, Knuechel R (2002a) Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol 17:599–621PubMedGoogle Scholar
  75. Kunz-Schughart LA, Knuechel R (2002b) Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol 17:623–637PubMedGoogle Scholar
  76. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C (2001) Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 10:1907–1913PubMedGoogle Scholar
  77. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32:355–357PubMedGoogle Scholar
  78. Kurosumi M, Tabei T, Inoue K, et al (2003) Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients. Oncol Rep 10:833–837PubMedGoogle Scholar
  79. Kurozumi K, Nakamura K, Tamiya T, et al (2004) BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9:189–197PubMedGoogle Scholar
  80. Kurozumi K, Nakamura K, Tamiya T, et al (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11:96–104PubMedGoogle Scholar
  81. Lange C, Togel F, Ittrich H, et al (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68:1613–1617PubMedGoogle Scholar
  82. Lazarus HM, Koc ON, Devine SM, et al (2005) Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389–398PubMedGoogle Scholar
  83. Le Blanc K, Pittenger M (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36–45PubMedGoogle Scholar
  84. Le Blanc K, Rasmusson I, Sundberg B, et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441PubMedGoogle Scholar
  85. Mansilla E, Marin GH, Sturla F, et al (2005) Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries. Transplant Proc 37:292–294PubMedGoogle Scholar
  86. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555PubMedGoogle Scholar
  87. McCullough KD, Coleman WB, Ricketts SL, Wilson JW, Smith GJ, Grisham JW (1998) Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Natl Acad Sci U S A 95:15333–15338PubMedGoogle Scholar
  88. McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ (2004) Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6:311–317PubMedGoogle Scholar
  89. Mintz B, Illmensee K (1975) Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A 72:3585–3589PubMedGoogle Scholar
  90. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562–2566PubMedGoogle Scholar
  91. Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849PubMedGoogle Scholar
  92. Nakamizo A, Marini F, Amano T, et al (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307–3318PubMedGoogle Scholar
  93. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S, Yasunaga Y (2004) Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 10:1093–1112PubMedGoogle Scholar
  94. Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M (2003) Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 75:248–255PubMedGoogle Scholar
  95. Orimo A, Gupta PB, Sgroi DC, et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335–348PubMedGoogle Scholar
  96. Ortiz LA, Gambelli F, McBride C, et al (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407–8411PubMedGoogle Scholar
  97. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14:506–514PubMedGoogle Scholar
  98. Philip M, Rowley DA, Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433–439PubMedGoogle Scholar
  99. Phinney DG, Isakova I (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 11:1255–1265PubMedGoogle Scholar
  100. Pittenger MF, Mackay AM, Beck SC, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147PubMedGoogle Scholar
  101. Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51:635–642PubMedGoogle Scholar
  102. Prindull G, Zipori D (2004) Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 103:2892–2899PubMedGoogle Scholar
  103. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74PubMedGoogle Scholar
  104. Prockop DJ, Sekiya I, Colter DC (2001) Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 3:393–396PubMedGoogle Scholar
  105. Radisky DC, Levy DD, Littlepage LE, et al (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123–127PubMedGoogle Scholar
  106. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615–2625PubMedGoogle Scholar
  107. Richter G, Kruger-Krasagakes S, Hein G, et al (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 53:4134–4137PubMedGoogle Scholar
  108. Robinson SC, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159–187PubMedGoogle Scholar
  109. Rojas M, Xu J, Woods CR, et al (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145–152PubMedGoogle Scholar
  110. Roni V, Habeler W, Parenti A, et al (2003) Recruitment of human umbilical vein endothelial cells and human primary fibroblasts into experimental tumors growing in SCID mice. Exp Cell Res 287:28–38PubMedGoogle Scholar
  111. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ (1995) The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95:859–873PubMedGoogle Scholar
  112. Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76:69–125PubMedGoogle Scholar
  113. Rowley DR (1998) What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17:411–419PubMedGoogle Scholar
  114. Rubio D, Garcia-Castro J, Martin MC, et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035–3039PubMedGoogle Scholar
  115. Sakakura T, Nishizuka Y, Dawe CJ (1976) Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. Science 194:1439–1441PubMedGoogle Scholar
  116. Sangai T, Ishii G, Kodama K, et al (2005) Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma. Int J Cancer 115:885–892PubMedGoogle Scholar
  117. Sato Y, Araki H, Kato J, et al (2005) Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106:756–763PubMedGoogle Scholar
  118. Satoh H, Kishi K, Tanaka T, et al (2004) Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds. Cell Transplant 13:405–412PubMedGoogle Scholar
  119. Schoeberlein A, Holzgreve W, Dudler L, Hahn S, Surbek DV (2005) Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses. Am J Obstet Gynecol 192:1044–1052PubMedGoogle Scholar
  120. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530–541PubMedGoogle Scholar
  121. Serakinci N, Guldberg P, Burns JS, et al (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095–5098PubMedGoogle Scholar
  122. Silva GV, Litovsky S, Assad JA, et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150–156PubMedGoogle Scholar
  123. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz-Schughart LA (2003) Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33:1311–1320PubMedGoogle Scholar
  124. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA (2004) The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 108:173–180PubMedGoogle Scholar
  125. Sivridis E, Giatromanolaki A, Koukourakis MI (2005) Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 58:1033–1038PubMedGoogle Scholar
  126. Sternlicht MD, Lochter A, Sympson CJ, et al (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146PubMedGoogle Scholar
  127. Sternlicht MD, Bissell MJ, Werb Z (2000) The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19:1102–1113PubMedGoogle Scholar
  128. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603–3608PubMedGoogle Scholar
  129. Studeny M, Marini FC, Dembinski JL, et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593–1603PubMedGoogle Scholar
  130. Sugimoto T, Takiguchi Y, Kurosu K, et al (2005) Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer. Oncol Rep 14:823–830PubMedGoogle Scholar
  131. Tlsty TD, Hein PW (2001) Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 11:54–59PubMedGoogle Scholar
  132. Wiesen JF, Young P, Werb Z, Cunha GR (1999) Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126:335–344PubMedGoogle Scholar
  133. Wright N, de Lera TL, Garcia-Moruja C, et al (2003) Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 102:1978–1984PubMedGoogle Scholar
  134. Xia Z, Ye H, Choong C, et al (2004) Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice. J Biomed Mater Res A 71:538–548PubMedGoogle Scholar
  135. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65:8887–8895PubMedGoogle Scholar
  136. Ye J, Yao K, Kim JC (2006) Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye 20:482–490PubMedGoogle Scholar
  137. Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328:679–687PubMedGoogle Scholar
  138. Zhu W, Xu W, Jiang R, et al (2006) Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 80:267–274PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  1. 1.Center for Childhood CancerColumbus Children’s Research InstituteColumbusUSA
  2. 2.Department of Blood and Marrow Transplantation, Unit 81The University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations